We evaluated whether targeted next-generation sequencing (NGS) using the Ion Torrent Personal Genome Sequencer of cfDNA could identify prognostic or predictive factors for overall survival (OS) or progression free survival (PFS) within a large cohort of patients with advanced lung adenocarcinoma enrolled in the GALAXY-1 trial.
| Accession | PRJEB20969 |
| Scope | Monoisolate |
| Submission | Registration date: 11-Jan-2018
MRC Toxicology Unit |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 306 |
| Other datasets |
| BioSample | 306 |